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The stimulatory substance (SS) that IS found In the cytosol of regenerating dog livers and which 
promoted regeneration when Injected into the portal vein after Eck fistula did not cause glomerular 
proliferation when active cytosol was injected into the renal artery, The finding was compatible 
with but did not prove organ specificity of hepatic SS, The development of SS was completely pre-
vented by extirpation of all nonhepatic splanchnic organs at the same time as partial hepatectomy, 
This finding Indicated that SS in the cytosol donors was a feature rather than an initiator of regenera-
lion. and one that depended upon the collaboration of extrahepatic (including splanchnic hepa-
totrophic) factors, 
INTRODUCTION 
We recently described a growth-stimu-
lating substance (SS) in the cytosol of re-
generating dog livers [5, 6]. Its intraportal 
injection could provoke regeneration in the 
livers of test animals that had just been sub-
mitted to portacaval shunt (Eck fistula) [5]. 
Such injections in animals with an intact 
liver circulation amplified the regeneration 
following partial hepatectomy [6]. The SS 
had the same general features as a rat liver 
factor described earlier by La Brecque and 
Pesch 121. 
Two unanswered questions about SS 
were examined in the present studies in 
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dogs. One about organ specificity was 
whether the hepatic SS could sti~ulate 
proliferation in the kidney if injected into 
the renal arterial supply. The second 
question was if the SS represented an 
autonomously developing response of the 
hepatic fragment or alternatively if its 
appearance required collaboration with the 
nonhepatic splanchnic organs and the 50-
called hepatotrophic factors (3) which 
emanate from these organs. 
METHODS 
Cytosol Preparation 
The cytosol was prepared from the intact 
liver or from liver fragments using the same 
ultracentrifugation techniques employed in 
earlier work by us [5, 6] and La Brecq~e and 
Pesch [21. The cytosol from about 100 g liver 
tissue constituted the infusion for one test 
animal. 
For kidney infusion. Previous canine 
studies had shown that the most potent SS 
appeared 3 days after 7'2% partial hepatec-
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to my [5J. Consequently. cytosol donors 
were killed this long after 72% hepatectomy. 
The activity of this liver cytosol was com-
pared to that of hepatic cytosol from normal 
animals. 
For liver infusioll. Cytosol was prepared 
from liver fragments 3 days after 44% 
hepatectomy in normal dogs. This cytosol 
was compared with that from the liver rem-
nants of dogs which 3 days earlier had simul-
taneous 44% hepatectomy and evisceration 
of all nonhepatic splanchnic organs from the 
esophagogastric junction to the anus in-
cluding the pancreas and spleen [3]. 
Cytosol Infusions 
Into kidney. Laparotomy was performed 
in normal dogs under anesthesia with 
sodium pentobarbital and phencyclidine 
hydrochloride. The left renal artery and 
aorta were exposed. After placing an 18-
gauge catheter into the left renal artery 
through the opposite aortic wall, infusion 
of the cytosol was carried out over 240 min. 
Killing was 3 days after injections of the 
cytosol obtained from normal or re-
generating livers. 
Into liver. The testing of liver responses 
was in an Eck fistula model [5]. Immedi-
ately after performing the portacaval shunt, 
the right portal vein was ligated. The left 
portal vein was also ligated and an infusion 
into it was carried out over 6 hr. The ani-
mals were killed 3 days after completion 
of the portacaval shunt and the beginning 
of the cytosol infusion. 
Histopathologic Studies 
All experimental endpoints were histo-
pathological as previously described [5, 6]. 
Two hours before killing many of the cytosol 
donors and all of the test animals injected 
with the cytosol were given 0.2 mCilkg 
[CH3-3H]thymidine (47 Cilmmole) intrave-
nously. Liver or kidney tissues were fixed 
in 10% buffered formaldehyde and ulti-
mately examined by light and electron 
microscopy. In the midlobular zones, the 
size of the hepatocytes was measured and 
expressed in arbitrary size units [3,5.6] and 
the volume of endoplasmic reticulum per 
volume of cytoplasm was determined 
[3, 5. 6]. Hepatocytes and glomerular cells 
in mitosis were counted [5. 6]. 
Other paraffin sections of liver and kidney 
were dewaxed. dipped in lIford K2 nuclear 
emulsion. and used for autoradiography. 
Exposure was for 4-8 weeks until counts 
of the labeled nuclei stopped increasing. 
With liver sections. only hepatocytes were 
counted. excluding stromal and other cells. 
In the kidney samples, labeled glomerular 
cells were recorded. 
RESULTS 
Renal Artery Infusions 
Although cytosol from 72-hr regenerating 
liver has been shown to cause major stimu-
lation of the Eck fistula liver [5], its intra-
arterial infusion caused no glomerular pro-
liferation in the injected or contralateral 
kidneys (Table 1). Cytosol from normal 
livers was also inactive (Table 1). 
The Effect of Evisceration upon 
Regeneration in Cytosol Donors 
The intact dogs submitted to 44% hepatec-
tomy had a brisk regeneration at the time 
of killing 3 days later (Table 2). The num-
bers of hepatocytes incorporating thymidine 
or undergoing actual mitoses were several 
times baseline and these cells were slightly 
enlarged. The regeneration response to 44% 
hepatectomy was approximately the same 
as previously reported. [1]. 
After 44% hepatectomy plus evisceration. 
there was no regeneration whatever in the 
liver fragments that were harvested 3 days 
later as a cytosol source (Table 2). The ab-
sence of regeneration after evisceration 
has been noted before [3]. 
Cytosol Infusions after Eck Fistula 
The cytosol obtained from normally 
regenerating livers after 44% hepatectomy 
-
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TABLE I 
EFFECT IN NORMAL DOGS 3 DAYS AFTER INJECTIONS INTO LEFT RENAL ARTERY OVER 240 MIN 
Number:!: SO per 1000 glomerular cells 
Labeled cells Mitoses 
No. Left kidney 
Uninjected controls 5 0.98 ± 0.129 
Cytosol from 
normal liver 10 0.99 ± 0.145 
Cytosol from 72-hr 
regenerating liver 10 0.97 :!: 0.244 
caused a brisk regeneration in the infused 
left liver lobes of the Eck fistula test dogs, 
but not on the right side (Table 3). Further-
more, the atrophy of Eck fistula was almost 
completely prevented in the left lobes 
(Table 3), as was the depletion of both 
smooth and rough endoplasmic reticulum. 
These effects were not caused by cytosol 
harvested from animals that had been sub-
mitted to evisceration plus 44% hepatec-
tomy (Table 3). 
DISCUSSION 
One question asked in this investigation 
was if the stimulatory effect of hepatic cyto-
sol was liver specific. Failure of active liver 
extracts given via the renal artery to stimu-
late proliferation of renal glomeruli could 
be consistent with such organ specificity. 
However. the experiments were not con-
Right kidney Left kidney Right kidney 
0.17 :!: 0.043 
0.95 :!: 0.139 0.20:!: 0.066 0.19 :!: 0.051 
0.95 :!: 0.164 0.17 :!: 0.034 0.18 :!: 0.047 
strued as proof of specificity. Even when 
active cytosol was injected directly into the 
portal circulation in dogs, a stimulatory ef-
fect was not clearly seen in normal livers 
[6]. Instead, cytosol activity was demon-
strated after the procedures of minor hepa-
tectomy [2, 6] and portacaval shunt [5] which 
evoke the common feature of heightened 
background proliferation prior to the :ntra-
portal cytosol infusion. It could be a!DgiKl~ct 
that the principal effect of cytosol is to 
amplify proliferative responR~; that are al-
ready in process, a conditicon tnat did not 
pertain to the kidney at the time of the 
renal artery infusions. 
The second question was if SS could 
develop in liver fragments without the col-
laboration of the non hepatic splanchnic 
organs. Within the 3-day time frame of our 
experiments, the answer was no. As has 
been reported before [3], removal of the 
TABLE 2 
REGENERATION RESPONSE 3 DAYS AFTER 440f HEPATECTOMY 
Hepatocyte Labeled hepatocytes! Mitoses/1000 
No. size Units 1000 hepatocytes hepatocytes 
Normul controls 10" 0.173 :!: 0.013" 1.61 :!: 0.39 0.D7 :!: 0.03 
44'7r HepateclOmy only 7 0.191 :!: o.on 9.20 :!: 0.093* 0.87 :!: 0.01' 
44";( HepaleclOmy plus 
~visceral1on 3 0.173 :!: 0.034 1.17 .= 0.35 0.11 .= 0.004 
" Previouslv reported 151. 
/, Mean", SD . 
. Rc,ulh Iignfticantl~ different I P ~ 0.01 hy 5IUdent'" I le,IJ from normal control, and from 44(:j 
hcpateclOm\ plu, CVI'cemllon. 
p 
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TABLE :1 
;\.0 mIU'll'O 
_~ \..1;1\, ,iller ~~/; 
hepalcctom\ 
3 ga~ ... aller *·V; 
hepatectomy 
plu ... e"' ... .;erallon 
So. 
h" 
, mre"louIl~ reponed 1."1 
Cell 'tLC unl'" 
Lell 
n. I:!.'\ -= t) 01" 0.121 ~ 0.017 
0.164 ~ IJ 014' 0.128 ~ 0.020 
0.127:: 0.021 0.127 !: 0.019 
Laheled hepah)\,.'\ Ie, 
1000 hepalOq Ie ... 
Left 
9.10 ~ 1.61' .'n" . 0.51 
3.07 " 0.47 3.01 " 11.46 
Left 
o 14 • 11.04 0.15 " 0.04 
IUl ~ 0.11' 0.13 - 0.05 
11.14 " 0.11" 0.14 ~ 0.\14 
.. Re ... uh ... "Df~mlhcanll~ .. lIlleren! tP < 0.01 or p.-:: 0.005 by Studenf..; I testl from untreated animal .. Inu Infu"'lOnf, lrom the nght liver "de of 
the .. arne animal", ,mJ from animals with hepatiC q tosol from eVI .. ceraled dogs. 
nonhepatic splanchnic organs completely 
prevented regeneration in the residual liver 
remnants of cytosol donors after partial 
hepatectomy. However. it was conceivable 
that SS of intrinsic hepatic origin was ac-
cumulating in these nonregenerating liver 
remnants under the conditions of eviscera-
tion but that the stimulatory effects of SS 
could not be expressed in the absence of 
the so-called splanchnic hepatotrophic fac-
tors. This criticism did not apply in the 
second stage of experiments herein reported 
in that the cytosols from eviscerated 
dogs were tested in other animals and under 
conditions previously shown [5] to reveal SS. 
The conclusion was that SS developed in 
normal cytosol donors contemporaneously 
with and was an expression of regeneration 
rather than being a forerunner or inde-
pendent initiator of this process. 
Possibly SS could be a synthesis product 
of the liver that results from the confluence 
of extrahepatic factors. Proof or disproof 
of this hypothesis will await isolation of 
the stimulatory substance(s) and testing of 
such moieties in more sensItive systems 
including tissue culture, For now. the best 
evidence is that SS is not itself a common 
hormone such as insulin or glucagon [5, 6]. 
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